149 related articles for article (PubMed ID: 15579455)
41. Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine.
Visser CJ; de Weger RA; van Blokland WT; Seifert-Bock I; Kobrin MS; Korc M; Woutersen RA
Br J Cancer; 1996 Jul; 74(1):92-8. PubMed ID: 8679465
[TBL] [Abstract][Full Text] [Related]
42. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC; Klimstra DS; Varmus HE
Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
[TBL] [Abstract][Full Text] [Related]
43. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
44. Characterization of gastrin-cholecystokinin 2 receptor interaction in relation to c-fos induction.
Hollestelle MJ; Timmerman P; Meloen RH; Höppener JW
Endocr Relat Cancer; 2008 Mar; 15(1):301-9. PubMed ID: 18310296
[TBL] [Abstract][Full Text] [Related]
45. Stat3 and NF-kappaB activation prevents apoptosis in pancreatic carcinogenesis.
Greten FR; Weber CK; Greten TF; Schneider G; Wagner M; Adler G; Schmid RM
Gastroenterology; 2002 Dec; 123(6):2052-63. PubMed ID: 12454861
[TBL] [Abstract][Full Text] [Related]
46. Histogenesis of exocrine pancreatic cancer in the hamster model.
Pour PM
Environ Health Perspect; 1984 Jun; 56():229-43. PubMed ID: 6236973
[TBL] [Abstract][Full Text] [Related]
47. Origin and development of the precursor lesions in experimental pancreatic cancer in rats.
Bockman DE; Guo J; Büchler P; Müller MW; Bergmann F; Friess H
Lab Invest; 2003 Jun; 83(6):853-9. PubMed ID: 12808120
[TBL] [Abstract][Full Text] [Related]
48. The gastrin receptor promotes pancreatic growth in transgenic mice.
Yen TW; Sandgren EP; Liggitt HD; Palmiter RD; Zhou W; Hinds TR; Grippo PJ; McDonald JM; Robinson LM; Bell RH
Pancreas; 2002 Mar; 24(2):121-9. PubMed ID: 11854616
[TBL] [Abstract][Full Text] [Related]
49. Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas.
Smith JP; Cao H; Edmondson EF; Dasa SSK; Stern ST
Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944412
[TBL] [Abstract][Full Text] [Related]
50. Hyperplastic nodules and adenomas of exocrine pancreas in azaserine-treated rats.
Longnecker DS; Crawford BG
J Natl Cancer Inst; 1974 Aug; 53(2):573-7. PubMed ID: 4843277
[No Abstract] [Full Text] [Related]
51. Pten constrains centroacinar cell expansion and malignant transformation in the pancreas.
Stanger BZ; Stiles B; Lauwers GY; Bardeesy N; Mendoza M; Wang Y; Greenwood A; Cheng KH; McLaughlin M; Brown D; Depinho RA; Wu H; Melton DA; Dor Y
Cancer Cell; 2005 Sep; 8(3):185-95. PubMed ID: 16169464
[TBL] [Abstract][Full Text] [Related]
52. Interface between adaptive and neoplastic growth in the pancreas.
Longnecker DS
Gut; 1987; 28 Suppl(Suppl):253-8. PubMed ID: 3319812
[TBL] [Abstract][Full Text] [Related]
53. Fundamentals of transcription factors and their impact on pancreatic development and cancer.
Fernandez-Zapico ME; Bramati PS; Zakaria S; Kaczynski JA; Urrutia R
Pancreatology; 2003; 3(4):276-83. PubMed ID: 12890989
[TBL] [Abstract][Full Text] [Related]
54. Modification of tumor development in the pancreas.
Pour PM
Prog Exp Tumor Res; 1991; 33():108-31. PubMed ID: 1902958
[No Abstract] [Full Text] [Related]
55. Toxicology of the pancreas.
Scarpelli DG
Toxicol Appl Pharmacol; 1989 Dec; 101(3):543-54. PubMed ID: 2690399
[TBL] [Abstract][Full Text] [Related]
56. Gene expression meta-analysis in diffuse low-grade glioma and the corresponding histological subtypes.
Wang S; Jin F; Fan W; Liu F; Zou Y; Hu X; Xu H; Han P
Sci Rep; 2017 Sep; 7(1):11741. PubMed ID: 28924174
[TBL] [Abstract][Full Text] [Related]
57. MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.
Zhang R; Li M; Zang W; Chen X; Wang Y; Li P; Du Y; Zhao G; Li L
Tumour Biol; 2014 Jan; 35(1):837-44. PubMed ID: 23975374
[TBL] [Abstract][Full Text] [Related]
58. Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER.
Gigoux V; Fourmy D
Front Endocrinol (Lausanne); 2013; 4():50. PubMed ID: 23641235
[TBL] [Abstract][Full Text] [Related]
59. αv integrin: a new gastrin target in human pancreatic cancer cells.
Cayrol C; Bertrand C; Kowalski-Chauvel A; Daulhac L; Cohen-Jonathan-Moyal E; Ferrand A; Seva C
World J Gastroenterol; 2011 Oct; 17(40):4488-95. PubMed ID: 22110279
[TBL] [Abstract][Full Text] [Related]
60. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
Rozengurt E; Sinnett-Smith J; Kisfalvi K
Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
